FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of general formula (I), in the form of optical isomers or their mixtures, and its pharmaceutically acceptable salt, which show activity as α2δ ligand and affinity to a subunit of α2δ potential-dependent calcium channels. In formula each R1, R2, R2', R4, R5, R8 and R8' independently represents hydrogen atom, halogen atom or C1-C6 alkyl group; each R6 and R7 independently represents hydrogen atom or C1-C6 alkyl group; or R2 and R2' together with carbon atom whereto attached form C3-C7 cycloalkyl group; R3 represents hydrogen atom, C1-C6 alkyl group, C1-C6 alkylhalogenide group, C1-C6 alkoxy-C1-C6 alkyl group, C2-C6 alkenyl group, C2-C6 alkynyl group, C1-C6 alkylsulphanyl-C1-C6 alkyl group, C2-C7 acyloxy-C1-C6 alkyl group or C3-C7 cycloalkyl group.
EFFECT: preparing the pharmaceutical composition for treating and/or preventing pain.
25 cl, 19 tbl, 43 ex
Title | Year | Author | Number |
---|---|---|---|
CONDENSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE | 2007 |
|
RU2443698C2 |
SUBSTITUTED CARBONUCLEOSIDES DERIVATIVES USED AS ANTICANCER AGENTS | 2017 |
|
RU2712944C1 |
PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS | 2011 |
|
RU2606514C2 |
2-THIOSUBSTITUTED CARBAPENEMS, INTERMEDIATE COMPOUNDS FOR SYNTHESIS, METHODS OF SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2130457C1 |
GAMMA-AMINOBUTYRIC ACID (GABA) ANALOGUES FOR TREATMENT OF PAIN AND OTHER DISORDERS | 2014 |
|
RU2679407C1 |
RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
METHOD FOR PREPARING 6-ALKYLIDENEPENEM DERIVATIVES | 2003 |
|
RU2317297C2 |
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
SELECTIVE GLYCOSIDASE INHIBITORS AND USE THEREOF | 2011 |
|
RU2609210C2 |
Authors
Dates
2012-03-27—Published
2008-09-25—Filed